Literature DB >> 18802919

A common haplotype at the dopamine transporter gene 5' region is associated with attention-deficit/hyperactivity disorder.

Júlia P Genro1, Guilherme V Polanczyk, Cristian Zeni, Angélica S Oliveira, Tatiana Roman, Luis A Rohde, Mara H Hutz.   

Abstract

The dopamine transporter (DAT) is the major site of methylphenidate action, which is one of the main drugs used to treat attention-deficit/hyperactivity disorder (ADHD). Most association studies with ADHD focused in a VNTR at the 3'-untranslated region of the gene (3'UTR) presenting conflicting results. However, the most common explanation to inconsistent results is variable linkage disequilibrium with an adjacent functional variant, just a few number of DAT1 studies have reported LD structure across the gene. In this study, we screened 16 polymorphisms across the DAT1 gene to understand LD structure in a Brazilian sample of families with ADHD probands and to verify if there were evidence for a biased transmission of alleles and haplotypes from parents to their 243 children with ADHD. In the DSM-IV combined subtype, we observed a preferential transmission of the haplotype A/C/C/C/A derived from five SNPs (rs2550948, rs11564750, rs261759, rs2652511, rs2975223) in 5' region (P corrected = 0.018) and no association with any allele/haplotype at the 3' region of the gene, including the 3' VNTR and the VNTR of intron 8. These results suggest a role for the promoter region in ADHD susceptibility and that allele heterogeneity should be highly considered in DAT1 gene association studies highlighting the importance of this gene in the genetics of the disorder. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802919     DOI: 10.1002/ajmg.b.30863

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  24 in total

1.  Human dopamine transporter gene: differential regulation of 18-kb haplotypes.

Authors:  Ying Zhao; Nian Xiong; Yang Liu; Yanhong Zhou; Nuomin Li; Hong Qing; Zhicheng Lin
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

Review 2.  How animal models inform child and adolescent psychiatry.

Authors:  Hanna E Stevens; Flora M Vaccarino
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2015-02-12       Impact factor: 8.829

3.  The influence of genetic variants on striatal dopamine transporter and D2 receptor binding after TBI.

Authors:  Amy K Wagner; Joelle M Scanlon; Carl R Becker; Anne C Ritter; Christian Niyonkuru; Clifton E Dixon; Yvette P Conley; Julie C Price
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-21       Impact factor: 6.200

4.  Association between polymorphisms of the DBH and DAT1 genes and attention deficit hyperactivity disorder in children from Jordan.

Authors:  Mohammad Y Gharaibeh; Sajida Batayneh; Omar F Khabour; Azhar Daoud
Journal:  Exp Ther Med       Date:  2010-07-01       Impact factor: 2.447

5.  Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults.

Authors:  Lucas A de Azeredo; Diego L Rovaris; Nina R Mota; Evelise R Polina; Francine Z Marques; Verônica Contini; Eduardo S Vitola; Paulo Belmonte-de-Abreu; Luis A Rohde; Eugenio H Grevet; Claiton H D Bau
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-02-01       Impact factor: 5.270

6.  Epigenetics in Developmental Disorder: ADHD and Endophenotypes.

Authors:  Trevor Archer; Marlene Oscar-Berman; Kenneth Blum
Journal:  J Genet Syndr Gene Ther       Date:  2011-06-30

Review 7.  Molecular genetics of attention-deficit/hyperactivity disorder: an overview.

Authors:  Tobias Banaschewski; Katja Becker; Susann Scherag; Barbara Franke; David Coghill
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-02-10       Impact factor: 4.785

Review 8.  Candidate gene studies of ADHD: a meta-analytic review.

Authors:  Ian R Gizer; Courtney Ficks; Irwin D Waldman
Journal:  Hum Genet       Date:  2009-06-09       Impact factor: 4.132

9.  Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD.

Authors:  Verônica Contini; Marcelo M Victor; Francine Z C Marques; Guilherme P Bertuzzi; Carlos A I Salgado; Katiane L Silva; Nyvia O Sousa; Eugenio H Grevet; Paulo Belmonte-de-Abreu; Claiton H D Bau
Journal:  J Neural Transm (Vienna)       Date:  2010-01-05       Impact factor: 3.575

10.  Separating the wheat from the chaff: systematic identification of functionally relevant noncoding variants in ADHD.

Authors:  J H S Tong; Z Hawi; C Dark; T D R Cummins; B P Johnson; D P Newman; R Lau; A Vance; H S Heussler; N Matthews; M A Bellgrove; K C Pang
Journal:  Mol Psychiatry       Date:  2016-04-26       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.